시장보고서
상품코드
1276313

세계의 장질환 검사 시장 규모, 점유율 및 산업 동향 분석 보고서 : 최종 사용자별, 질환 유형별, 제품 유형별(시약 및 소모품, 기기), 검사 방법별, 지역별 전망 및 예측(2023-2029년)

Global Enteric Disease Testing Market Size, Share & Industry Trends Analysis Report By End User, By Disease Type, By Product Type (Reagents & Consumables and Equipment), By Technique, By Regional Outlook and Forecast, 2023 - 2029

발행일: | 리서치사: KBV Research | 페이지 정보: 영문 251 Pages | 배송안내 : 즉시배송

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

장질환 검사 시장 규모는 예측 기간 중 CAGR 3.2%로 성장하여 2029년에는 46억 달러에 달할 것으로 예상됩니다.

장질환은 장에 영향을 미치는 박테리아, 바이러스, 기생충 등 미생물에 의해 발생합니다. 이러한 질병은 대부분 사람 간 전염이 가능하며, 일반적으로 오염된 음식이나 음료 섭취로 인해 발생합니다. 장염의 증상으로는 메스꺼움, 복통, 오한, 발열, 설사, 식욕부진 등이 있습니다.

물이나 음식을 매개로 한 많은 질병은 장내 세균이 주요 원인인 것으로 알려져 있습니다. 설사와 용혈성 요독 증후군(HUS)은 세계에서 흔한 질병입니다. 장내 세균 감염은 가장 흔한 원인입니다. 장내 세균성 질환 검사 시장은 설사 발생률 증가, 신흥국에서의 발생률 증가, 정부의 인식 증가, 정부 및 공공 기관의 다양한 노력 등의 요인으로 인해 예측 기간 중 확대될 것으로 예상됩니다.

COVID-19의 영향 분석

코로나19 검사 및 치료는 전염병이 의료 우선순위에 영향을 미치면서 장질환 검사보다 우선순위가 높아졌고, 코로나19의 전염병은 코로나19 검사, 치료 및 백신 접종 노력에 대규모 자원 재분배가 필요했습니다. 이로 인해 장질환 검사와 같은 다른 의료 분야의 자원이 전용되었습니다. 이는 의료 역량 저하, 사회적 거리두기 등 여러 가지 요인이 복합적으로 작용한 결과이며, 코로나19 사태로 인해 많은 장질환 연구 프로젝트가 중단되고 자원과 인력이 코로나19 연구로 전환되었습니다. 전염병 기간 중 장질환 검사 키트에 대한 수요가 감소하여 시장 성장에 부정적인 영향을 미쳤습니다.

시장 성장 요인

세계 장질환의 유병률 증가

크로스트리듐 디피실(C. difficile), 이질, 대장균, 콜레라, 살모넬라증 등 심한 설사나 사망에 달할 수 있는 장질환의 유병률이 증가하고 있는 것도 이러한 검사에 대한 수요 증가에 기여하고 있습니다. 세계에서 매년 수백만 명의 사람들이 장질환을 앓고 있으며, 특히 위생 환경이 열악한 저개발 국가에서 많이 발생합니다. 따라서 장질환의 유병률 증가는 예측 기간 중 시장 성장을 가속할 것으로 보입니다.

연구개발 활성화에 따른 기술 혁신 증가

장질환 검사에 대한 수요는 장질환 검사 장비 및 검사 방법의 기술 개발 및 개선으로 혜택을 받을 수 있습니다. 검사 효율성 향상, 비용 효율적인 검사, 신속한 검사 결과는 제품 개발에 기여할 수 있습니다. 또한 헬스케어 사업에서 보다 효율적이고 효과적이며 합리적인 가격의 컴퓨팅 하드웨어가 네트워크 접속 강화, 소프트웨어 개선 및 고급 센서와 연결되는 경향이 증가하고 있습니다. 따라서 시장은 향후 수년간 이러한 변수로 인해 재정적 이익을 얻을 수 있습니다.

시장 성장 억제요인

검사 및 샘플링에 대한 높은 비용

자동화된 장질환 검사 장비는 그 고급 기능과 특성으로 인해 수동식 장비에 비해 높은 가격대를 형성하고 있습니다. 미디어, 장비 및 인건비를 계산하면 특정 최종 사용자에게는 매우 비싸게 느껴질 수 있습니다. 또한 실험실에 많은 시스템을 도입하는 것은 총 자본 비용에 대한 투자 금액을 크게 증가시킵니다. 분자 진단 기술, 특히 멀티플렉스 분석의 활용은 싱글플렉스 분석에 비해 헬스케어 산업에서 최근 발전한 기술입니다. 그러나 멀티플렉스 분석 장비의 비용은 상대적으로 비싸고 장비 도입에 필요한 초기 투자도 높습니다. 이 요인은 비용 효율적인 대안이 등장할 때까지 시장 성장을 저해하는 요인이 될 것입니다.

제품 유형 전망

제품 유형별로 장질환 검사 시장은 시약 및 소모품 및 장비로 분류되며, 2022년 장질환 검사 시장에서 장비 부문은 상당한 성장률을 확보했습니다. 다양한 유형의 장질환 검사가 공정에 사용되어 이 부문의 성장을 주도하고 있습니다. 자동 분석기는 장질환에 대한 신속한 검사를 수행하는 데 사용됩니다. 이러한 테스트는 샘플에서 병원균의 특정 항원 또는 유전 물질의 존재를 감지 할 수 있습니다.

검사 방법의 전망

장질환 검사 시장은 검사 방법별로 분자 진단과 면역 진단으로 분류됩니다. 면역 진단 부문은 2022년 장질환 검사 시장에서 가장 큰 매출 점유율을 차지할 것으로 예상됩니다. 면역 진단 검사는 때로는 몇 시간 만에 결과를 얻을 수 있으므로 장질환의 조기 진단 및 치료가 가능합니다. 면역진단검사는 소량의 병원체나 항체로도 검출이 가능하기 때문에 민감하고 특이적인 검사가 가능합니다. 즉, 특정 병원균의 존재를 정확하게 확인하고 환자의 증상을 유발할 수 있는 다른 가능성을 배제할 수 있습니다.

질병 유형별 전망

장질환 검사 시장은 질병 유형에 따라 세균성, 바이러스성, 기생충성 등 세 가지로 분류됩니다. 살모넬라증, 콜레라, 대장균, 헬리코박터 파일로리 등 세균성 장질환의 높은 유병률과 이를 진단하기 위한 장질환 검사 제품의 보급이 이 시장 부문의 성장을 주도하고 있습니다. 또한 세균성 장질환 진단에 대한 지식이 향상되고 세계에서 세균성 장질환 발생률이 증가함에 따라 이 부문은 빠르게 성장할 것으로 예상됩니다.

최종 사용자 전망

최종 사용자별로 장질환 검사 시장은 학술 및 연구 기관, 병원 연구소, 제약 및 바이오테크놀러지 기업으로 분류됩니다. 학술 및 연구 기관 부문은 2022년 장질환 검사 시장에서 상당한 매출 점유율을 차지했습니다. 학술 및 연구 기관은 장질환의 공중 보건 감시에서 중요한 역할을 담당하고 있습니다. 집단에서 장질환을 검사하고 모니터링하면 발병을 식별하고, 대응 계획을 수립하고, 예방 및 관리 전략을 실행하는 데 도움이 됩니다. 연구 기관은 장질환을 유발하는 새로운 병원균을 식별하는 데 중요한 역할을 합니다.

지역별 전망

지역별로 장질환 검사 시장은 북미, 유럽, 아시아태평양, LAMEA로 분석됩니다. 북미 부문은 2022년 장질환 검사 시장에서 가장 큰 매출 점유율을 기록했습니다. 이 지역의 장질환 검사 제품 제조 기술의 향상뿐만 아니라 많은 주요 기업의 존재가 시장 확대를 촉진하고 있습니다. 이는 주로 장질환 환자 증가, 장질환 진단 연구에 대한 정부 지원 증가, 선진국의 자본 소득이 크게 증가했기 때문입니다.

시장 진입자들이 취하는 주요 전략은 인수합병입니다. Cardinal Matrix에 제시된 분석에 따르면 Thermo Fisher Scientific, Inc.는 장질환 검사 시장의 선구자이며, Neogen Corporation, Bureau Veritas S.A., Eurofins Scientific SE와 같은 기업들은 장질환 검사 시장의 주요 혁신 기업입니다. 장질환 검사 시장의 주요 혁신 기업 중 하나입니다.

목차

제1장 시장 범위와 조사 방법

  • 시장의 정의
  • 목적
  • 시장 범위
  • 세분화
    • 세계의 장질환 검사 시장 : 최종사용자별
    • 세계의 장질환 검사 시장 : 질환 유형별
    • 세계의 장질환 검사 시장 : 제품 유형별
    • 세계의 장질환 검사 시장 : 검사 방법별
    • 세계의 장질환 검사 시장 : 지역별
  • 조사 방법

제2장 시장 개요

  • 서론
    • 개요
      • 시장 구성과 시나리오
  • 시장에 영향을 미치는 주요 요인
    • 시장 촉진요인
    • 시장 억제요인

제3장 경쟁 분석 - 세계

  • KBV 카디널 매트릭스
  • 최근 업계 전체의 전략적 개발
    • 파트너십, 협업 및 계약
    • 제품 발매와 제품의 확대
    • 인수합병
  • 주요 성공 전략
    • 주요 리딩 전략

제4장 세계의 장질환 검사 시장 : 최종사용자별

  • 세계의 병원 랩 시장 : 지역별
  • 세계의 제약·바이오테크놀러지 기업 시장 : 지역별
  • 세계의 학술·연구기관 시장 : 지역별

제5장 세계의 장질환 검사 시장 : 질환 유형별

  • 세계의 세균 시장 : 지역별
  • 세계의 바이러스 시장 : 지역별
  • 세계의 기생충 시장 : 지역별

제6장 세계의 장질환 검사 시장 : 제품 유형별

  • 세계의 시약·소모품 시장 : 지역별
  • 세계의 기기 시장 : 지역별

제7장 세계의 장질환 검사 시장 : 검사 방법별

  • 세계의 면역진단 시장 : 지역별
  • 세계의 분자진단 시장 : 지역별

제8장 세계의 장질환 검사 시장 : 지역별

  • 북미
    • 북미의 시장 : 국가별
      • 미국
      • 캐나다
      • 멕시코
      • 기타 북미 지역
  • 유럽
    • 유럽의 시장 : 국가별
      • 독일
      • 영국
      • 프랑스
      • 러시아
      • 스페인
      • 이탈리아
      • 기타 유럽 지역
  • 아시아태평양
    • 아시아태평양의 시장 : 국가별
      • 중국
      • 일본
      • 인도
      • 한국
      • 싱가포르
      • 말레이시아
      • 기타 아시아태평양
  • 라틴아메리카·중동 및 아프리카
    • 라틴아메리카·중동 및 아프리카의 시장 : 국가별
      • 브라질
      • 아르헨티나
      • 아랍에미리트
      • 사우디아라비아
      • 남아프리카공화국
      • 나이지리아
      • 기타 라틴아메리카·중동 및 아프리카

제9장 기업 개요

  • Thermo Fisher Scientific, Inc
  • Becton, Dickinson and Company
  • Neogen Corporation
  • Bureau Veritas SA
  • SGS SA
  • Eurofins Scientific SE
  • Merck KGaA
  • PerkinElmer, Inc
  • Intertek Group PLC
  • TUV Nord Group
KSA 23.06.14

The Global Enteric Disease Testing Market size is expected to reach $4.6 billion by 2029, rising at a market growth of 3.2% CAGR during the forecast period.

Infections of the gastrointestinal tract, encompassing the small intestine, large intestine, and stomach, are known as enteric diseases. Bacteria, viruses, and parasites are just a few of the microorganisms that might cause these diseases. Salmonellosis, shigellosis, norovirus, rotavirus, amebiasis, cryptosporidiosis, and giardiasis are typical examples of enteric diseases. Others include cholera, Clostridium difficile (C. difficile), Escherichia coli (E. coli), shigellosis, and Helicobacter pylori (H. pylori).

To determine the exact pathogen triggering an enteric disease and to diagnose enteric diseases, numerous laboratory tests are employed. These tests often entail checking samples of blood, feces, or other fluids from the body for the presence of viruses, bacteria, and parasites known as enteric pathogens.

Enteric disorders are caused by bacterial, viral, and parasitic microorganisms that affect the intestines. Many of these illnesses can be spread from person to person and are typically brought on by consuming tainted food or drink. The symptoms of enteric infections include nausea, stomach pain, chills, fever, diarrhea, and loss of appetite.

One of the primary agents behind many water- and food-borne illnesses has been shown to be enteric bacteria. Diarrhea and hemolytic uremic syndrome (HUS) are becoming more common worldwide. Enteric bacterial infections are the most frequent cause. The enteric disease testing market is expected to expand throughout the forecast period due to factors such as rising rates of diarrhea, rising rates in emerging nations, higher government awareness, and various government and public sector initiatives.

COVID-19 Impact Analysis

COVID-19 testing and treatment took precedence over enteric illness testing as a result of the pandemic's impact on healthcare priorities. The COVID-19 pandemic required a massive redirection of resources towards COVID-19 testing, treatment, and vaccination efforts. This led to a diversion of resources away from other areas of healthcare, including enteric disease testing. This was due to a combination of factors, including reduced healthcare capacity, and social distancing measures. The COVID-19 pandemic disrupted many research projects related to enteric diseases, with resources and personnel being diverted towards COVID-19 research. The demand for enteric disease testing kits decreased during the pandemic, which negatively impacted market growth.

Market Growth Factors

Increasing prevalence of enteric disease worldwide

The rise in the prevalence of several other enteric diseases such as clostridium difficile (C. difficile), shigellosis, Escherichia coli (E. coli), cholera, and salmonellosis-all of which can result in severe diarrhea or even death-also contributes to the increasing demand for these tests. Rising Millions of people contract enteric infections every year worldwide, but they are particularly prevalent in underdeveloped nations with subpar sanitation. Hence, the rising prevalence of enteric disease will propel the growth of the market throughout the forecast period.

Rising number of technological breakthroughs owing to increased R&D

The demand for enteric disease testing may benefit from the growing technological developments and improvements in enteric disease testing equipment and methods. Testing efficiency gains, cost-effective testing, and quick test results may contribute to product development. Additionally, the healthcare business is embracing the growing trend of more efficient, effective, and affordable computing hardware connected to greater network connectivity, improved software, and advanced sensors. In light of this, the market may benefit financially from these variables in the years to come.

Market Restraining Factors

High cost of testing and sampling

Automated enteric disease testing instruments are priced higher than their manual counterparts due to their advanced features and functions. The calculated cost of the media, instrument, and labor may be perceived as prohibitively expensive by certain end users. In addition, implementing numerous systems in testing laboratories has significantly increased the total capital cost investment. Utilizing molecular diagnostic techniques, particularly multiplexed assays, is a recent development in the healthcare industry compared to singleplex assays. However, the cost of multiplexed assay equipment is comparatively high, and the initial investment required for instrument installation is higher. This factor will impede the market's growth until cost-effective alternatives become available.

Product Type Outlook

Based on product type, the enteric disease testing market is characterized into reagents & consumables and equipment. The equipment segment procured a considerable growth rate in the enteric disease testing market in 2022. Different types of enteric disease testing are used in the process, which is propelling the growth of the segment. Automated analyzers are used to perform rapid tests for enteric diseases. These tests can detect the presence of specific antigens or genetic material from the pathogen in a sample.

Technique Outlook

On the basis of technique, the enteric disease testing market is classified into molecular diagnostics and immunodiagnostics. The immunodiagnostics segment acquired the largest revenue share in the enteric disease testing market in 2022. Immunodiagnostic tests can provide results quickly, sometimes in as little as a few hours, which allows for earlier diagnosis and treatment of enteric diseases. Immunodiagnostic tests can detect even small amounts of pathogens or antibodies, making them highly sensitive and specific. This means they can accurately identify the presence of a specific pathogen and rule out other potential causes of the patient's symptoms.

Disease Type Outlook

By disease type, the enteric disease testing market is divided into bacterial, viral, and parasitic. The high prevalence of bacterial enteric diseases such as salmonellosis, cholera, E. coli, and Helicobacter pylori, as well as the widespread utilization of enteric disease testing products for the diagnosis, are driving the growth of this market segment. In addition, due to increased knowledge of bacterial enteric disease diagnosis and a rising incidence of bacterial enteric diseases globally, the category is anticipated to experience rapid growth.

End User Outlook

Based on end user, the enteric disease testing market is segmented into academic & research institutes, hospital laboratories, and pharmaceutical & biotechnology companies. The academic & research institutes segment acquired a substantial revenue share in the enteric disease testing market in 2022. Academic and research institutes play a vital role in public health surveillance for enteric diseases. Testing and monitoring of enteric diseases in populations can help in identifying outbreaks, developing response plans, and implementing prevention and control strategies. Research institutes play a crucial role in identifying new pathogens responsible for enteric diseases.

Regional Outlook

Region wise, the enteric disease testing market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment recorded the largest revenue share in the enteric disease testing market in 2022. The presence of a number of significant players as well as improvements in the manufacturing technology of enteric disease testing products in the region is what is driving the market's expansion. This is mostly due to an increase in the number of patients with enteric diseases, increased government support for research into the diagnosis of enteric diseases, and a sizable increase in capital income in industrialized nations.

The major strategies followed by the market participants are Acquisitions. Based on the Analysis presented in the Cardinal matrix; Thermo Fisher Scientific, Inc. is the forerunner in the Enteric Disease Testing Market. Companies such as Neogen Corporation, Bureau Veritas S.A., and Eurofins Scientific SE are some of the key innovators in Enteric Disease Testing Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck KGaA, Thermo Fisher Scientific, Inc., SGS S.A., Eurofins Scientific SE, Bureau Veritas S.A., Intertek Group PLC, TUV Nord Group, PerkinElmer, Inc., Becton, Dickinson and Company and Neogen Corporation.

Recent Strategies Deployed in Enteric Disease Testing Market

Mergers and Acquisitions:

Jan-2023: Thermo Fisher Scientific Inc. took over The Binding Site Group, a global leader in specialty diagnostics. Through this acquisition, Thermo Fisher Scientific Inc. would be able to extend its current specialty diagnostics portfolio along with pioneering innovation in monitoring and diagnostics for numerous myelomas.

Sep-2022: Bureau Veritas took over Galbraith Laboratories, a US-based operator of contract analytical testing. The addition of Galbraith expands the acquiring company's market presence in the personal care, industrial, and consumer healthcare markets, and further expands Bureau Veritas' market position in the North American region.

Sep-2022: Neogen announced the completion of a merger with 3M's Food Safety business. 3M's food safety business is merged with Neogen. The combination expands the merged company's geographical footprint, digitization capabilities, etc.

Jul-2022: Neogen completed the acquisition of Thai-Neo Biotech, a Thailand-based distributor of food safety products. The acquisition enables the acquiring company to establish a direct presence in Thailand and the Southeast Asian region. Further, the addition of Thai-Neo Biotech perfectly complements Neogen's operations in China, Australia, and India.

Jun-2022: Eurofins acquired a majority stake in Ajal for Laboratories, a Saudi Arabia-based provider of laboratory services. This acquisition broadens the acquiring company's food and pharmaceutical product test offerings in Saudi Arabia. Further, the acquisition reflects Eurofins' commitment to developing a local and regional laboratory network across the whole Middle East.

Sep-2021: Neogen acquired CAPInnoVet, a US-based provider of animal health medicines and products. This acquisition provides Neogen entry to the retail parasiticide market. The acquired company will be a part of Neogen's Animal Safety business segment.

Apr-2021: Thermo Fisher Scientific Inc. took over PPD, Inc., a pharmaceutical company engaged in clinical research. Through this acquisition, the company would provide a vast range of services in the clinical development spectrum. This includes the development and manufacturing of the drug product, healthcare outcomes, trial logistics., scientific discovery, etc.

Partnerships, Collaborations and Agreements:

Oct-2022: Thermo Fisher Scientific came into partnership with Genoox, a provider of fast and accurate tools to solve complex, genomic data challenges, delivering advanced, and end-to-end genomic analysis tools. The partnership aims to automate the interpretation and reporting of cytogenetic research data with AI. ChAS users can access Franklin, Genoox's cloud-based AI platform with the launch of CytoScan Automated Interpretation and Reporting (AIR) solution for making cytogenetic research data analysis easy.

Apr-2022: SGS came into partnership with Liveome, a South Korea-based operator of microbiome research-based firm. The partnership focuses on the development and commercialization of LIV001, an inflammatory bowel disease (IBD) candidate. The partnership demonstrates SGS' ability to provide its services globally.

Product Launches and Expansions:

Dec-2022: Thermo Fisher introduced TrueMark Infectious Disease Research Panels, developed to enable quick and precise detection and categorization for investigating microorganisms. The new panel are real-time polymerase chain reaction (PCR) syndromic panels and gives an option to the user to choose between standard or custom panels.

Oct-2022: Thermo Fisher launched TaqPath Enteric Bacterial Select Panel, a CE-IVD marked test intended for common Gastrointestinal bacteria. The new test detects gastrointestinal (GI) bacteria and speeds up the root cause identification process. The GI bacteria detecting test is based on polymerase chain reaction (PCR) technology to examine the stool samples. The test can deliver results with 98% specificity, and sensitivity within two hours.

Scope of the Study

Market Segments covered in the Report:

By End User

  • Hospital Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes

By Disease Type

  • Bacterial
  • Viral
  • Parasitic

By Product Type

  • Reagents & Consumables
  • Equipment

By Technique

  • Immunodiagnostics
  • Molecular Diagnostics

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • SGS S.A.
  • Eurofins Scientific SE
  • Bureau Veritas S.A.
  • Intertek Group PLC
  • TUV Nord Group
  • PerkinElmer, Inc.
  • Becton, Dickinson and Company
  • Neogen Corporation

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Enteric Disease Testing Market, by End User
    • 1.4.2 Global Enteric Disease Testing Market, by Disease Type
    • 1.4.3 Global Enteric Disease Testing Market, by Product Type
    • 1.4.4 Global Enteric Disease Testing Market, by Technique
    • 1.4.5 Global Enteric Disease Testing Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)

Chapter 4. Global Enteric Disease Testing Market by End User

  • 4.1 Global Hospital Laboratories Market by Region
  • 4.2 Global Pharmaceutical & Biotechnology Companies Market by Region
  • 4.3 Global Academic & Research Institutes Market by Region

Chapter 5. Global Enteric Disease Testing Market by Disease Type

  • 5.1 Global Bacterial Market by Region
  • 5.2 Global Viral Market by Region
  • 5.3 Global Parasitic Market by Region

Chapter 6. Global Enteric Disease Testing Market by Product Type

  • 6.1 Global Reagents & Consumables Market by Region
  • 6.2 Global Equipment Market by Region

Chapter 7. Global Enteric Disease Testing Market by Technique

  • 7.1 Global Immunodiagnostics Market by Region
  • 7.2 Global Molecular Diagnostics Market by Region

Chapter 8. Global Enteric Disease Testing Market by Region

  • 8.1 North America Enteric Disease Testing Market
    • 8.1.1 North America Enteric Disease Testing Market by End User
      • 8.1.1.1 North America Hospital Laboratories Market by Country
      • 8.1.1.2 North America Pharmaceutical & Biotechnology Companies Market by Country
      • 8.1.1.3 North America Academic & Research Institutes Market by Country
    • 8.1.2 North America Enteric Disease Testing Market by Disease Type
      • 8.1.2.1 North America Bacterial Market by Country
      • 8.1.2.2 North America Viral Market by Country
      • 8.1.2.3 North America Parasitic Market by Country
    • 8.1.3 North America Enteric Disease Testing Market by Product Type
      • 8.1.3.1 North America Reagents & Consumables Market by Country
      • 8.1.3.2 North America Equipment Market by Country
    • 8.1.4 North America Enteric Disease Testing Market by Technique
      • 8.1.4.1 North America Immunodiagnostics Market by Country
      • 8.1.4.2 North America Molecular Diagnostics Market by Country
    • 8.1.5 North America Enteric Disease Testing Market by Country
      • 8.1.5.1 US Enteric Disease Testing Market
        • 8.1.5.1.1 US Enteric Disease Testing Market by End User
        • 8.1.5.1.2 US Enteric Disease Testing Market by Disease Type
        • 8.1.5.1.3 US Enteric Disease Testing Market by Product Type
        • 8.1.5.1.4 US Enteric Disease Testing Market by Technique
      • 8.1.5.2 Canada Enteric Disease Testing Market
        • 8.1.5.2.1 Canada Enteric Disease Testing Market by End User
        • 8.1.5.2.2 Canada Enteric Disease Testing Market by Disease Type
        • 8.1.5.2.3 Canada Enteric Disease Testing Market by Product Type
        • 8.1.5.2.4 Canada Enteric Disease Testing Market by Technique
      • 8.1.5.3 Mexico Enteric Disease Testing Market
        • 8.1.5.3.1 Mexico Enteric Disease Testing Market by End User
        • 8.1.5.3.2 Mexico Enteric Disease Testing Market by Disease Type
        • 8.1.5.3.3 Mexico Enteric Disease Testing Market by Product Type
        • 8.1.5.3.4 Mexico Enteric Disease Testing Market by Technique
      • 8.1.5.4 Rest of North America Enteric Disease Testing Market
        • 8.1.5.4.1 Rest of North America Enteric Disease Testing Market by End User
        • 8.1.5.4.2 Rest of North America Enteric Disease Testing Market by Disease Type
        • 8.1.5.4.3 Rest of North America Enteric Disease Testing Market by Product Type
        • 8.1.5.4.4 Rest of North America Enteric Disease Testing Market by Technique
  • 8.2 Europe Enteric Disease Testing Market
    • 8.2.1 Europe Enteric Disease Testing Market by End User
      • 8.2.1.1 Europe Hospital Laboratories Market by Country
      • 8.2.1.2 Europe Pharmaceutical & Biotechnology Companies Market by Country
      • 8.2.1.3 Europe Academic & Research Institutes Market by Country
    • 8.2.2 Europe Enteric Disease Testing Market by Disease Type
      • 8.2.2.1 Europe Bacterial Market by Country
      • 8.2.2.2 Europe Viral Market by Country
      • 8.2.2.3 Europe Parasitic Market by Country
    • 8.2.3 Europe Enteric Disease Testing Market by Product Type
      • 8.2.3.1 Europe Reagents & Consumables Market by Country
      • 8.2.3.2 Europe Equipment Market by Country
    • 8.2.4 Europe Enteric Disease Testing Market by Technique
      • 8.2.4.1 Europe Immunodiagnostics Market by Country
      • 8.2.4.2 Europe Molecular Diagnostics Market by Country
    • 8.2.5 Europe Enteric Disease Testing Market by Country
      • 8.2.5.1 Germany Enteric Disease Testing Market
        • 8.2.5.1.1 Germany Enteric Disease Testing Market by End User
        • 8.2.5.1.2 Germany Enteric Disease Testing Market by Disease Type
        • 8.2.5.1.3 Germany Enteric Disease Testing Market by Product Type
        • 8.2.5.1.4 Germany Enteric Disease Testing Market by Technique
      • 8.2.5.2 UK Enteric Disease Testing Market
        • 8.2.5.2.1 UK Enteric Disease Testing Market by End User
        • 8.2.5.2.2 UK Enteric Disease Testing Market by Disease Type
        • 8.2.5.2.3 UK Enteric Disease Testing Market by Product Type
        • 8.2.5.2.4 UK Enteric Disease Testing Market by Technique
      • 8.2.5.3 France Enteric Disease Testing Market
        • 8.2.5.3.1 France Enteric Disease Testing Market by End User
        • 8.2.5.3.2 France Enteric Disease Testing Market by Disease Type
        • 8.2.5.3.3 France Enteric Disease Testing Market by Product Type
        • 8.2.5.3.4 France Enteric Disease Testing Market by Technique
      • 8.2.5.4 Russia Enteric Disease Testing Market
        • 8.2.5.4.1 Russia Enteric Disease Testing Market by End User
        • 8.2.5.4.2 Russia Enteric Disease Testing Market by Disease Type
        • 8.2.5.4.3 Russia Enteric Disease Testing Market by Product Type
        • 8.2.5.4.4 Russia Enteric Disease Testing Market by Technique
      • 8.2.5.5 Spain Enteric Disease Testing Market
        • 8.2.5.5.1 Spain Enteric Disease Testing Market by End User
        • 8.2.5.5.2 Spain Enteric Disease Testing Market by Disease Type
        • 8.2.5.5.3 Spain Enteric Disease Testing Market by Product Type
        • 8.2.5.5.4 Spain Enteric Disease Testing Market by Technique
      • 8.2.5.6 Italy Enteric Disease Testing Market
        • 8.2.5.6.1 Italy Enteric Disease Testing Market by End User
        • 8.2.5.6.2 Italy Enteric Disease Testing Market by Disease Type
        • 8.2.5.6.3 Italy Enteric Disease Testing Market by Product Type
        • 8.2.5.6.4 Italy Enteric Disease Testing Market by Technique
      • 8.2.5.7 Rest of Europe Enteric Disease Testing Market
        • 8.2.5.7.1 Rest of Europe Enteric Disease Testing Market by End User
        • 8.2.5.7.2 Rest of Europe Enteric Disease Testing Market by Disease Type
        • 8.2.5.7.3 Rest of Europe Enteric Disease Testing Market by Product Type
        • 8.2.5.7.4 Rest of Europe Enteric Disease Testing Market by Technique
  • 8.3 Asia Pacific Enteric Disease Testing Market
    • 8.3.1 Asia Pacific Enteric Disease Testing Market by End User
      • 8.3.1.1 Asia Pacific Hospital Laboratories Market by Country
      • 8.3.1.2 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country
      • 8.3.1.3 Asia Pacific Academic & Research Institutes Market by Country
    • 8.3.2 Asia Pacific Enteric Disease Testing Market by Disease Type
      • 8.3.2.1 Asia Pacific Bacterial Market by Country
      • 8.3.2.2 Asia Pacific Viral Market by Country
      • 8.3.2.3 Asia Pacific Parasitic Market by Country
    • 8.3.3 Asia Pacific Enteric Disease Testing Market by Product Type
      • 8.3.3.1 Asia Pacific Reagents & Consumables Market by Country
      • 8.3.3.2 Asia Pacific Equipment Market by Country
    • 8.3.4 Asia Pacific Enteric Disease Testing Market by Technique
      • 8.3.4.1 Asia Pacific Immunodiagnostics Market by Country
      • 8.3.4.2 Asia Pacific Molecular Diagnostics Market by Country
    • 8.3.5 Asia Pacific Enteric Disease Testing Market by Country
      • 8.3.5.1 China Enteric Disease Testing Market
        • 8.3.5.1.1 China Enteric Disease Testing Market by End User
        • 8.3.5.1.2 China Enteric Disease Testing Market by Disease Type
        • 8.3.5.1.3 China Enteric Disease Testing Market by Product Type
        • 8.3.5.1.4 China Enteric Disease Testing Market by Technique
      • 8.3.5.2 Japan Enteric Disease Testing Market
        • 8.3.5.2.1 Japan Enteric Disease Testing Market by End User
        • 8.3.5.2.2 Japan Enteric Disease Testing Market by Disease Type
        • 8.3.5.2.3 Japan Enteric Disease Testing Market by Product Type
        • 8.3.5.2.4 Japan Enteric Disease Testing Market by Technique
      • 8.3.5.3 India Enteric Disease Testing Market
        • 8.3.5.3.1 India Enteric Disease Testing Market by End User
        • 8.3.5.3.2 India Enteric Disease Testing Market by Disease Type
        • 8.3.5.3.3 India Enteric Disease Testing Market by Product Type
        • 8.3.5.3.4 India Enteric Disease Testing Market by Technique
      • 8.3.5.4 South Korea Enteric Disease Testing Market
        • 8.3.5.4.1 South Korea Enteric Disease Testing Market by End User
        • 8.3.5.4.2 South Korea Enteric Disease Testing Market by Disease Type
        • 8.3.5.4.3 South Korea Enteric Disease Testing Market by Product Type
        • 8.3.5.4.4 South Korea Enteric Disease Testing Market by Technique
      • 8.3.5.5 Singapore Enteric Disease Testing Market
        • 8.3.5.5.1 Singapore Enteric Disease Testing Market by End User
        • 8.3.5.5.2 Singapore Enteric Disease Testing Market by Disease Type
        • 8.3.5.5.3 Singapore Enteric Disease Testing Market by Product Type
        • 8.3.5.5.4 Singapore Enteric Disease Testing Market by Technique
      • 8.3.5.6 Malaysia Enteric Disease Testing Market
        • 8.3.5.6.1 Malaysia Enteric Disease Testing Market by End User
        • 8.3.5.6.2 Malaysia Enteric Disease Testing Market by Disease Type
        • 8.3.5.6.3 Malaysia Enteric Disease Testing Market by Product Type
        • 8.3.5.6.4 Malaysia Enteric Disease Testing Market by Technique
      • 8.3.5.7 Rest of Asia Pacific Enteric Disease Testing Market
        • 8.3.5.7.1 Rest of Asia Pacific Enteric Disease Testing Market by End User
        • 8.3.5.7.2 Rest of Asia Pacific Enteric Disease Testing Market by Disease Type
        • 8.3.5.7.3 Rest of Asia Pacific Enteric Disease Testing Market by Product Type
        • 8.3.5.7.4 Rest of Asia Pacific Enteric Disease Testing Market by Technique
  • 8.4 LAMEA Enteric Disease Testing Market
    • 8.4.1 LAMEA Enteric Disease Testing Market by End User
      • 8.4.1.1 LAMEA Hospital Laboratories Market by Country
      • 8.4.1.2 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
      • 8.4.1.3 LAMEA Academic & Research Institutes Market by Country
    • 8.4.2 LAMEA Enteric Disease Testing Market by Disease Type
      • 8.4.2.1 LAMEA Bacterial Market by Country
      • 8.4.2.2 LAMEA Viral Market by Country
      • 8.4.2.3 LAMEA Parasitic Market by Country
    • 8.4.3 LAMEA Enteric Disease Testing Market by Product Type
      • 8.4.3.1 LAMEA Reagents & Consumables Market by Country
      • 8.4.3.2 LAMEA Equipment Market by Country
    • 8.4.4 LAMEA Enteric Disease Testing Market by Technique
      • 8.4.4.1 LAMEA Immunodiagnostics Market by Country
      • 8.4.4.2 LAMEA Molecular Diagnostics Market by Country
    • 8.4.5 LAMEA Enteric Disease Testing Market by Country
      • 8.4.5.1 Brazil Enteric Disease Testing Market
        • 8.4.5.1.1 Brazil Enteric Disease Testing Market by End User
        • 8.4.5.1.2 Brazil Enteric Disease Testing Market by Disease Type
        • 8.4.5.1.3 Brazil Enteric Disease Testing Market by Product Type
        • 8.4.5.1.4 Brazil Enteric Disease Testing Market by Technique
      • 8.4.5.2 Argentina Enteric Disease Testing Market
        • 8.4.5.2.1 Argentina Enteric Disease Testing Market by End User
        • 8.4.5.2.2 Argentina Enteric Disease Testing Market by Disease Type
        • 8.4.5.2.3 Argentina Enteric Disease Testing Market by Product Type
        • 8.4.5.2.4 Argentina Enteric Disease Testing Market by Technique
      • 8.4.5.3 UAE Enteric Disease Testing Market
        • 8.4.5.3.1 UAE Enteric Disease Testing Market by End User
        • 8.4.5.3.2 UAE Enteric Disease Testing Market by Disease Type
        • 8.4.5.3.3 UAE Enteric Disease Testing Market by Product Type
        • 8.4.5.3.4 UAE Enteric Disease Testing Market by Technique
      • 8.4.5.4 Saudi Arabia Enteric Disease Testing Market
        • 8.4.5.4.1 Saudi Arabia Enteric Disease Testing Market by End User
        • 8.4.5.4.2 Saudi Arabia Enteric Disease Testing Market by Disease Type
        • 8.4.5.4.3 Saudi Arabia Enteric Disease Testing Market by Product Type
        • 8.4.5.4.4 Saudi Arabia Enteric Disease Testing Market by Technique
      • 8.4.5.5 South Africa Enteric Disease Testing Market
        • 8.4.5.5.1 South Africa Enteric Disease Testing Market by End User
        • 8.4.5.5.2 South Africa Enteric Disease Testing Market by Disease Type
        • 8.4.5.5.3 South Africa Enteric Disease Testing Market by Product Type
        • 8.4.5.5.4 South Africa Enteric Disease Testing Market by Technique
      • 8.4.5.6 Nigeria Enteric Disease Testing Market
        • 8.4.5.6.1 Nigeria Enteric Disease Testing Market by End User
        • 8.4.5.6.2 Nigeria Enteric Disease Testing Market by Disease Type
        • 8.4.5.6.3 Nigeria Enteric Disease Testing Market by Product Type
        • 8.4.5.6.4 Nigeria Enteric Disease Testing Market by Technique
      • 8.4.5.7 Rest of LAMEA Enteric Disease Testing Market
        • 8.4.5.7.1 Rest of LAMEA Enteric Disease Testing Market by End User
        • 8.4.5.7.2 Rest of LAMEA Enteric Disease Testing Market by Disease Type
        • 8.4.5.7.3 Rest of LAMEA Enteric Disease Testing Market by Product Type
        • 8.4.5.7.4 Rest of LAMEA Enteric Disease Testing Market by Technique

Chapter 9. Company Profiles

  • 9.1 Thermo Fisher Scientific, Inc.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
    • 9.1.4 Research & Development Expenses
    • 9.1.5 Recent strategies and developments:
      • 9.1.5.1 Partnerships, Collaborations, and Agreements:
      • 9.1.5.2 Product Launches and Product Expansions:
      • 9.1.5.3 Acquisition and Mergers:
    • 9.1.6 SWOT Analysis
  • 9.2 Becton, Dickinson and Company
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Segmental and Regional Analysis
    • 9.2.4 Research & Development Expense
    • 9.2.5 SWOT Analysis
  • 9.3 Neogen Corporation
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expenses
    • 9.3.5 Recent strategies and developments:
      • 9.3.5.1 Acquisition and Mergers:
  • 9.4 Bureau Veritas S.A.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expenses
    • 9.4.5 Recent strategies and developments:
      • 9.4.5.1 Acquisition and Mergers:
  • 9.5 SGS S.A.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Segmental Analysis
    • 9.5.4 Recent strategies and developments:
      • 9.5.4.1 Partnerships, Collaborations, and Agreements:
  • 9.6 Eurofins Scientific SE
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Regional Analysis
    • 9.6.4 Recent strategies and developments:
      • 9.6.4.1 Acquisition and Mergers:
  • 9.7 Merck KGaA
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental and Regional Analysis
    • 9.7.4 Research & Development Expense
  • 9.8 PerkinElmer, Inc.
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Segmental and Regional Analysis
    • 9.8.4 Research & Development Expense
  • 9.9 Intertek Group PLC
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Segmental and Regional Analysis
    • 9.9.4 Research & Development Expenses
  • 9.10. TUV Nord Group
    • 9.10.1 Company Overview
    • 9.10.2 Financial Analysis
    • 9.10.3 Segmental and Regional Analysis
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제